NIH launches early-stage yellow fever vaccine trial
NIAID announced an early-stage clinical trial of an investigational vaccine designed to protect against yellow fever virus. The Phase 1 study is evaluating whether an experimental vaccine developed by Bavarian Nordic is safe, tolerable and has the potential to prevent yellow fever virus infection. July 27, 2016